BIO-RAD LABORATORIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 279.9 USD | 0.00% |
|
0.00% | -12.71% |
| 05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
| 05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
MarketScreener Editorial Features
Search
 | Slow start for Wall Street | January 03, 2024 at 02:38 pm |
 | Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom... | January 03, 2024 at 10:31 am |
 | ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox... | October 27, 2023 at 11:04 am |
 | ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express... | June 16, 2023 at 10:52 am |
 | Global markets live: Exxon Mobil, Eli Lilly, Solvay, Meta, AstraZeneca... | October 11, 2022 at 04:43 pm |
 | ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings... | August 25, 2022 at 10:17 am |
 | GLOBAL MARKETS LIVE: easyJet, AT&T, Warner Bros… | June 15, 2020 at 04:19 pm |
No results for this search
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock
- News Bio-Rad Laboratories, Inc.
- MarketScreener Editorial Features
